VEGFA and lung cancer: In particular, several crucial molecular pathways involved in the efficacy of curcumin as an anti-lung cancer drug involve the vascular endothelial growth factor (VEGF), EGFR, nuclear factor-κB (NF-κB), and mammalian target of rapamycin (mTOR) pathways [169].